Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Long-Term Debt Repayments (2017 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Long-Term Debt Repayments for 14 consecutive years, with $10.1 billion as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Repayments changed N/A to $10.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.8 billion through Dec 2025, up 344.66% year-over-year, with the annual reading at $10.9 billion for FY2025, 280.79% up from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $10.1 billion at Bristol Myers Squibb, up from $229.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $10.1 billion in Q4 2025, with the low at $229.0 million in Q3 2025.
  • Average Long-Term Debt Repayments over 5 years is $2.7 billion, with a median of $2.0 billion recorded in 2023.
  • The sharpest move saw Long-Term Debt Repayments surged 457.0% in 2022, then plummeted 91.69% in 2023.
  • Over 5 years, Long-Term Debt Repayments stood at $500.0 million in 2021, then soared by 457.0% to $2.8 billion in 2022, then decreased by 28.19% to $2.0 billion in 2023, then rose by 23.9% to $2.5 billion in 2024, then skyrocketed by 306.3% to $10.1 billion in 2025.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $10.1 billion, $229.0 million, and $2.5 billion for Q4 2025, Q3 2025, and Q3 2024 respectively.